+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

SIFI SpA - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 26 Pages
  • September 2023
  • GlobalData
  • ID: 4076487
SIFI SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The publisher's summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

SIFI SpA (SIFI) is an ophthalmic company. It develops, manufactures, and markets pharmaceutical products, diagnostic instruments, and surgical equipment for the prevention and treatment of ocular pathologies. SIFI develops its products in various dosage forms including ointments, eye drops, pills, and capsules. Its products find application in the areas of corneal abrasions, cataracts, glaucoma, infections, inflammation, corneal lesions, periocular hygiene, dry eye, and retinopathies. It conducts research in the areas of diagnostics and surgery. SIFI operates directly in Italy, Spain, France, Romania, Mexico, and Turkey. SIFI is headquartered in Catania, Italy.

SIFI SpA Key Recent Developments

  • May 02, 2023: SIFI presented new data on XanterDES at ARVO 2023

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • SIFI SpA - Key Facts
  • SIFI SpA - Key Employees
  • SIFI SpA - Key Operational Employees
  • SIFI SpA - Major Products and Services
  • SIFI SpA - History
  • SIFI SpA - Company Statement
  • SIFI SpA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • SIFI SpA - Business Description
  • R&D Overview
  • SIFI SpA - SWOT Analysis
  • SWOT Analysis - Overview
  • SIFI SpA - Strengths
  • SIFI SpA - Weaknesses
  • SIFI SpA - Opportunities
  • SIFI SpA - Threats
  • SIFI SpA - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • SIFI SpA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • SIFI SpA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • SIFI SpA, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • May 02, 2023: SIFI presented new data on XanterDES at ARVO 2023
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • SIFI SpA, Key Facts
  • SIFI SpA, Key Employees
  • SIFI SpA, Key Operational Employees
  • SIFI SpA, Major Products and Services
  • SIFI SpA, History
  • SIFI SpA, Subsidiaries
  • SIFI SpA, Key Competitors
  • SIFI SpA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • SIFI SpA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • SIFI SpA, Recent Deals Summary
List of Figures
  • SIFI SpA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • SIFI SpA, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alfa Intes srl
  • Optikon 2000 SpA
  • LTL S.p.A
  • Bruschettini Srl